Blog

Home  /  Get Involved   /  Open Call for Patient Input – Joint Assessment on a Medicinal Product for DBLCL.

Open Call for Patient Input – Joint Assessment on a Medicinal Product for DBLCL.

EUnetHTA recently started a new Joint Assessment on a medicinal product for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for hematopoietic stem cell transplant.

To find out more about how patient input can contribute to this assessment, please read further here.

Input is greatly appreciated up till end of 31st March, 2019.